Ordinary Index Rebalancing in the Solactive Global Vaccines and Infectious Diseases Index | August 2022

In the ordinary rebalance the following composition will be implemented effective open 15.08.2022:

3SBIO INC
ADAPTIVE BIOTECHNOLOGIES CORP
ASTRAZENECA PLC
BIONTECH SE
CANSINO BIOLOGICS INC
CHO PHARMA INC
CUREVAC BV
DYNAVAX TECHNOLOGIES CORP
ELI LILLY & CO
EMERGENT BIOSOLUTIONS INC
GSK PLC
IMMUNITYBIO INC
IMUGENE LTD
JOHNSON & JOHNSON
LABORATORY CRP OF AMER HLDGS
MARAVAI LIFESCIENCES HOLDINGS INC
MERCK & CO. INC.
MERIDIAN BIOSCIENCE INC
MODERNA INC
NOVAVAX INC
OPKO HEALTH INC
PFIZER INC
QUIDELORTHO CORPORATION
REGENERON PHARMACEUTICALS
SANOFI SA
SHANGHAI JUNSHI BIOSCIENCES CO LTD
VALNEVA SE
VAXCYTE INC
VIR BIOTECHNOLOGY INC
XENCOR INC